Rob Cutler - 22 Jun 2023 Form 4 Insider Report for Telesis Bio Inc. (TBIO)

Role
Chief Legal Officer
Signature
/s/ Rob Cutler
Issuer symbol
TBIO
Transactions as of
22 Jun 2023
Net transactions value
-$727
Form type
4
Filing time
05 Mar 2024, 18:04:21 UTC
Previous filing
08 May 2023
Next filing
29 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TBIO Common Stock Award $0 +13,800 +59% $0.000000 37,094 22 Jun 2023 Direct F1
transaction TBIO Common Stock Tax liability $727 -1,376 -3.7% $0.5280 35,718 01 Mar 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TBIO Stock Option (right to buy) Award $0 +111,800 $0.000000 111,800 22 Jun 2023 Common Stock 111,800 $1.66 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Issuer's Common Stock for each RSU. Subject to the Reporting Person's continuing as a Service Provider (as defined in the Issuer's 2021 Stock Incentive Plan (the "Plan")) through each applicable vesting date, 25% of the RSUs shall vest on each of March 1, 2024, March 1, 2025, March 1, 2026, and March 1, 2027.
F2 Represents the number of shares withheld by the Issuer to satisfy the tax withholding obligation in connection with the vesting of RSUs.
F3 Subject to the Reporting Person's continuing as a Service Provider (as defined in the Plan) through each applicable vesting date, twenty-five percent (25%) of the shares subject to the option shall vest on March 1, 2024, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter.